Clinical Trial Update: PRIMA PFO Migraine Trial [Phase 2]

View source ↗

Summary

Abbott Medical Devices reports that the PRIMA PFO Migraine Trial, a Phase 2 study investigating PFO closure for migraine, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Migraine with Aura
• Patent Foramen Ovale

Drugs mentioned

• Amplatzer PFO Occluder

Snippet

Sponsor: Abbott Medical Devices | Conditions: Migraine, Migraine With Aura | Phase 2 | Status: TERMINATED